Latest Breaking News On - வாக்களியுங்கள் இருக்கிறது முக்கியமான - Page 1 : comparemela.com

Obalon Therapeutics Continues to Urge Stockholders to Vote FOR All Proposals Related to Merger with ReShape Lifesciences ACCESSWIRE 21 May 2021, 21:43 GMT+10 SAN DIEGO, CA / ACCESSWIRE / May 21, 2021 / Obalon Therapeutics, Inc. (NASDAQ:OBLN), a vertically integrated medical technology company with the first and only FDA-approved swallowable gas-filled intragastric balloon system for the treatment of obesity, is taking this opportunity to remind its stockholders to vote on all the proposals related to the proposed merger with ReShape Lifesciences Inc. in advance of the upcoming reconvened special meeting of Obalon stockholders (the Special Meeting ) on May 25, 2021, at 8:30 a.m. PT. All stockholders are highly encouraged to vote by phone or email on this critical transaction. Without the required stockholder approval, the merger will not be able to be completed. The failure to complete the merger may result in, among other things, a material adverse effect on Obalon and its sto

Avenida encinasObalon therapeutics incLife sciences incObalon therapeuticsReshape lifesciencesSpecial meetingVote is importantHow few shares youMackenzie partnersSan diego basedAdditional informationRegistration statementUnited states wire groupஅவெனிட எண்சினச்வாழ்க்கை அறிவியல் இன்க்மறுவடிவமைப்பு ஆயுள் அறிவியல்